A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: solid (48), dense (12), thick (51)

Cyclophosphamide-Etoposide PO Ver 1.1

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-ETOPOSIDE ORAL Regimen Lymphoma – Cyclophosphamide-Etoposide PO Indication Palliative treatment of malignant lymphoma Toxicity Drug Adverse E
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Cyclophosphamide-Etoposide-PO-Ver-1.1.pdf

Bexarotene

Description
Chemotherapy Protocol Cutaneous T-cell Lymphoma BEXAROTENE Regimen • Cutaneous T-cell Lymphoma - Bexarotene Indication • Bexarotene is indicated for the treatment of skin manifestations of advanced stage
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Bexarotene.pdf

Sunitinib v1

Description
Chemotherapy Protocol SARCOMA Gastro-Intestinal Stromal Tumour (GIST) Regimen Sunitinib GIST-Sunitinib Indication Sunitinib is recommended as
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Sunitinib-v1.pdf

Regorafenib

Description
Chemotherapy Protocol Gastro-Intestinal Stromal Tumour Regorafenib Regimen • GIST – Regorafenib Indication • Regorafenib is recommended for histologically confirmed metastatic or unresectable gastr
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Regorafenib.pdf

Regorafenib

Description
Chemotherapy Protocol Hepatocellular Cancer Regorafenib Regimen • Hepatocellular – Regorafenib Indication • Regorafenib is recommended as an option for treating advanced unresectable hepatocellular
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Regorafenib.pdf

Ponatinib

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Ponatinib All licensed indications are not funded therefore an application for funding is
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Ponatinib.pdf

NilotinibChronic

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (chronic phase) Regimen • CML – Nilotinib (chronic phase) Indication • As an option for the treatment of patients with newly dia
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibChronic.pdf

NilotinibAccelerated

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (accelerated phase) Regimen • CML – Nilotinib (accelerated phase) Indication • Nilotinib is an option for the treatment of Phila
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibAccelerated.pdf

Hydroxycarbamide

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia (CML) Hydroxycarbamide Regimen • CML - Hydroxycarbamide Indication • Chronic or accelerated phase chronic myeloid leukaemia in tho
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Hydroxycarbamide.pdf

DasatinibChronic

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia DASATINIB (chronic phase) Funding may be required for specific indications Regimen • CML – Dasatinib (chronic phase) Indic
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/DasatinibChronic.pdf
291 to 300 of 533
Previous … 28 29 30 31 32 … Next